Literature DB >> 34490519

Pediatric Onco-Nephrology: Time to Spread the Word-Part II: Long-Term Kidney Outcomes in Survivors of Childhood Malignancy and Malignancy after Kidney Transplant.

Arwa Nada1, Jennifer G Jetton2.   

Abstract

Onco-nephrology is a recent and evolving medical subspecialty devoted to the care of patients with kidney disease and unique kidney-related complications in the context of cancer and its treatments, recognizing that management of kidney disease as well as the cancer itself will improve survival and quality of life. While this area has received much attention in the adult medicine sphere, similar emphasis in the pediatric realm has not yet been realized. As in adults, kidney involvement in children with cancer extends beyond the time of initial diagnosis and treatment. Many interventions, such as chemotherapy, stem cell transplant, radiation, and nephrectomy, have long-term kidney effects, including the development of chronic kidney disease (CKD) with subsequent need for dialysis and/or kidney transplant. Thus, with the improved survival of children with malignancy comes the need for ongoing monitoring of kidney function and early mitigation of kidney-related comorbidities. In addition, children with kidney transplant are at higher risk of developing malignancies than their age-matched peers. Pediatric nephrologists thus need to be aware of issues related to cancer and its treatments as they impact their own patients. These facts emphasize the necessity of pediatric nephrologists and oncologists working closely together in managing these children and highlight the importance of bringing the onco-nephrology field to our growing list of pediatric nephrology subspecialties.
© 2021. IPNA.

Entities:  

Keywords:  Cancer; Children; Chronic kidney disease; Kidney outcome; Post-kidney transplant malignancies; Radiation

Mesh:

Year:  2021        PMID: 34490519     DOI: 10.1007/s00467-021-05172-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  101 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Renal function in survivors of nonsyndromic Wilms tumor treated with unilateral radical nephrectomy.

Authors:  Rodrigo B Interiano; Noel Delos Santos; Sujuan Huang; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson; Daniel M Green; Andrew M Davidoff
Journal:  Cancer       Date:  2015-04-01       Impact factor: 6.860

3.  Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors.

Authors:  Sebastiaan L Knijnenburg; Monique W Jaspers; Helena J van der Pal; Antoinette Y Schouten-van Meeteren; Antonia H Bouts; Jan A Lieverst; Arend Bökenkamp; Caro C E Koning; Foppe Oldenburger; James C H Wilde; Flora E van Leeuwen; Huib N Caron; Leontien C Kremer
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 8.237

Review 4.  Cancer and the kidney.

Authors:  Christina M Keaney; James E Springate
Journal:  Adolesc Med Clin       Date:  2005-02

5.  Renal function after unilateral nephrectomy for Wilms' tumour: the influence of radiation therapy.

Authors:  S S de Graaf; H van Gent; W C Reitsma-Bierens; W H van Luyk; W V Dolsma; A Postma
Journal:  Eur J Cancer       Date:  1996-03       Impact factor: 9.162

6.  National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors:  Andrew S Levey; Josef Coresh; Ethan Balk; Annamaria T Kausz; Adeera Levin; Michael W Steffes; Ronald J Hogg; Ronald D Perrone; Joseph Lau; Garabed Eknoyan
Journal:  Ann Intern Med       Date:  2003-07-15       Impact factor: 25.391

7.  Diastolic hypertension in Wilms' tumor survivors: a late effect of treatment? A report from the National Wilms' Tumor Study Group.

Authors:  J Z Finklestein; P Norkool; D M Green; N Breslow; G J D'Angio
Journal:  Am J Clin Oncol       Date:  1993-06       Impact factor: 2.339

Review 8.  The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research.

Authors:  Leslie L Robison; Gregory T Armstrong; John D Boice; Eric J Chow; Stella M Davies; Sarah S Donaldson; Daniel M Green; Sue Hammond; Anna T Meadows; Ann C Mertens; John J Mulvihill; Paul C Nathan; Joseph P Neglia; Roger J Packer; Preetha Rajaraman; Charles A Sklar; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

9.  Focal glomerulosclerosis and proteinuria in patients with solitary kidneys.

Authors:  V Gutierrez-Millet; J Nieto; M Praga; G Usera; M A Martinez; J M Morales
Journal:  Arch Intern Med       Date:  1986-04

10.  Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study. United Kingdom Children's Cancer Study Group.

Authors:  R Skinner; S J Cotterill; M C Stevens
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.